as 07-26-2024 4:00pm EST
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | ST LOUIS |
Market Cap: | 41.9B | IPO Year: | 2001 |
Target Price: | $84.00 | AVG Volume (30 days): | 4.5M |
Analyst Decision: | Buy | Number of Analysts: | 15 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 5.05 | EPS Growth: | 88.43 |
52 Week Low/High: | $60.83 - $81.42 | Next Earning Date: | 07-26-2024 |
Revenue: | $155,517,000,000 | Revenue Growth: | 6.34% |
Revenue Growth (this year): | -2.12% | Revenue Growth (next year): | 3.74% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
COUGHLIN CHRISTOPHER J | CNC | Director | May 14 '24 | Sell | $76.75 | 878 | $67,382.11 | 0 | SEC Form 4 |
FASOLA KENNETH J | CNC | President | May 13 '24 | Sell | $77.62 | 8,000 | $620,960.00 | 300,357 | SEC Form 4 |
Robinson Lori Jean | CNC | Director | Feb 13 '24 | Sell | $77.41 | 10,000 | $774,100.00 | 11,455 | SEC Form 4 |
FASOLA KENNETH J | CNC | President | Feb 7 '24 | Sell | $74.83 | 8,190 | $612,857.70 | 239,175 | SEC Form 4 |
FASOLA KENNETH J | CNC | President | Feb 7 '24 | Sell | $75.58 | 3,810 | $287,959.80 | 235,365 | SEC Form 4 |
CNC Breaking Stock News: Dive into CNC Ticker-Specific Updates for Smart Investing
Investopedia
6 hours ago
Zacks
7 hours ago
MT Newswires
7 hours ago
Motley Fool
8 hours ago
Morningstar Research
8 hours ago
Zacks
10 hours ago
Zacks
10 hours ago
Zacks
12 hours ago
The information presented on this page, "CNC Centene Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.